INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PLYMOUTH MEETING, Pa., Nov. 16, 2020 /PRNewswire-AsiaNet/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that it has received clearance from the U.S. Food & Drug A...
Authors: LATEST ASIANET NEWS RELEASES